References S-Z

SABIT, R., GRIFFITHS, T. L., WATKINS, A. J., EVANS, W., BOLTON, C. E., SHALE, D. J. & LEWIS, K. E. 2008. Predictors of poor attendance at an outpatient pulmonary rehabilitation programme. Respir Med, 102, 819-24.
SAJKOV, D., MCEVOY, R. D., COWIE, R. J., BRADLEY, J. A., ANTIC, R., MORRIS, R. G. & FRITH, P. A. 1993. Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease. Chest, 103, 1354-61.
SAJKOV, D., WANG, T., FRITH, P. A., BUNE, A. J., ALPERS, J. A. & MCEVOY, R. D. 1997. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. Chest, 111, 1622-30.
SAKAE, T. M., PIZZICHINI, M. M., TEIXEIRA, P. J., SILVA, R. M., TREVISOL, D. J. & PIZZICHINI, E. 2013. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol, 39, 259-71.
SALPETER, S. R., BUCKLEY, N. S. & SALPETER, E. E. 2006. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med, 21, 1011-9.
SALPETER, S. R., ORMISTON, T. M. & SALPETER, E. E. 2004. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest, 125, 2309-21.
SALPETER, S., ORMISTON, T. & SALPETER, E. 2002. Cardioselective beta-blockers for reversible airway disease. Cochrane Database Syst Rev, 4, CD002992.
SALPETER, S., ORMISTON, T. & SALPETER, E. 2005. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 4, CD003566.
SANCHIS, J., GICH, I. & PEDERSEN, S. 2016. Systematic Review of Errors in Inhaler Use: Has Patient Technique Improved Over Time? . Chest, 150, 394-406.
SANKAR, A., THORPE, K., MCISAAC, D. I., LUO, J., WIJEYSUNDERA, D. N. & GERSHON, A. S. 2023. Survival and health care costs after inpatient elective surgery: comparison of patients with and without chronic obstructive pulmonary disease. Canadian Medical Association Journal, 195, E62-E71.
SANTO TOMAS, L. H. 2011. Emphysema and chronic obstructive pulmonary disease in coal miners. Curr Opin Pulm Med, 17, 123-5.
SARWAR, M. R., MCDONALD, V. M., ABRAMSON, M. J., MCLOUGHLIN, R. F., GEETHADEVI, G. M. & GEORGE, J. 2022. Effectiveness of Interventions Targeting Treatable Traits for the Management of Obstructive Airway Diseases: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pract, 10, 2333-2345e21.
SASAKI, T., NAKAYAMA, K., YASUDA, H., YOSHIDA, M., ASAMURA, T., OHRUI, T., ARAI, H., ARAYA, J., KUWANO, K. & YAMAYA, M. 2009. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc, 57, 1453-7.
SCHARF, S. M., IQBAL, M., KELLER, C., CRINER, G., LEE, S. & FESSLER, H. E. 2002. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med, 166, 314-22.
SCHEERENS, C., FAES, K., PYPE, P., BEERNAERT, K., JOOS, G., DEROM, E., COHEN, J., DELIENS, L. & CHAMBAERE, K. 2020. Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study. Eur Respir J, 55, 1901139.
SCHERMER, T. R., SARIS, C. G., VAN DEN BOSCH, W. J., CHAVANNES, N. H., VAN SCHAYCK, C. P., DEKHUIJZEN, P. N. & VAN WEEL, C. 2006. Exacerbations and associated healthcare cost in patients with COPD in general practice. Monaldi Arch Chest Dis, 65, 133-40.
SCHERMER, T., VAN WEEL, C., BARTEN, F., BUFFELS, J., CHAVANNES, N., KARDAS, P., OSTREM, A., SCHNEIDER, A. & YAMAN, H. 2008. Prevention and management of chronic obstructive pulmonary disease (COPD) in primary care: position paper of the European Forum for Primary Care. Qual Prim Care, 16, 363-77.
SCHNELL, K., WEISS, C. O., LEE, T., KRISHNAN, J. A., LEFF, B., WOLFF, J. L. & BOYD, C. 2012. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med, 12, 26.
SCHNIEDERS, E., ÜNAL, E., WINKLER, V., DAMBACH, P., LOUIS, V. R., HORSTICK, O., NEUHANN, F. & DECKERT, A. 2021. Performance of alternative COPD case-finding tools: a systematic review and meta-analysis. Eur Respir Rev, 30, 200350.
SCHOLS, A. M., BROEKHUIZEN, R., WELING-SCHEEPERS, C. A. & WOUTERS, E. F. 2005. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr, 82, 53-9.
SCHONHOFER, B., WENZEL, M., GEIBEL, M. & KOHLER, D. 1998. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med, 26, 1824-8.
SCHOU, L., OSTERGAARD, B., RASMUSSEN, L. S., RYDAHL-HANSEN, S. & PHANARETH, K. 2012. Cognitive dysfunction in patients with chronic obstructive pulmonary disease–a systematic review. Respir Med, 106, 1071-81.
SCHRIJVER, J., LENFERINK, A., BRUSSE-KEIZER, M., ZWERINK, M., VAN DER VALK, P. D., VAN DER PALEN, J. & EFFING, T. W. 2022. Self-management interventions for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 1, Cd002990.
SCHWARTZ, J. L. 1987. Review and Evaluation of Smoking Cessation Methods: The United States and Canada. 1978-1985 (NIH Publication No.87-2940)., Bethesda MD, National Cancer Institute, National Institutes of Health.
SEDENTARY BEHAVIOUR RESEARCH NETWORK . 2012. Letter to the editor: standardized use of the terms “sedentary” and “sedentary behaviours”. Appl Physiol Nutr Metab, 37, 540-2.
SEEMUNGAL, T. A., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J. & WEDZICHA, J. A. 2000. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 161, 1608-13.
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MACCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L. & WEDZICHA, J. A. 2001. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 164, 1618-23.
SEGRELLES CALVO, G., GOMEZ-SUAREZ, C., SORIANO, J. B., ZAMORA, E., GONZALEZ-GAMARRA, A., GONZALEZ-BEJAR, M., JORDAN, A., TADEO, E., SEBASTIAN, A., FERNANDEZ, G. & ANCOCHEA, J. 2014. A home telehealth program for patients with severe COPD: the PROMETE study. Respir Med, 108, 453-62.
SELROOS, O., BORGSTROM, L. & INGELF, J. 2009. Use of dry powder inhalers in acute exacerbations of asthma and COPD. Ther Adv Respir Dis, 3, 81-91.
SENDEROVITZ, T., VESTBO, J., FRANDSEN, J., MALTBAEK, N., NORGAARD, M., NIELSEN, C. & KAMPMANN, J. P. 1999. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease The Danish Society of Respiratory Medicine. Respir Med, 93, 715-8.
SERGINSON, J. G., YANG, I. A., ARMSTRONG, J. G., COOPER, D. M., MATTHIESSON, A. M., MORRISON, S. C., GAIR, J. M., COOPER, B. & ZIMMERMAN, P. V. 2009. Variability in the rate of prescription and cost of domiciliary oxygen therapy in Australia. Med J Aust, 191, 549-53.
SEYS, D., BRUYNEEL, L., DECRAMER, M., LODEWIJCKX, C., PANELLA, M., SERMEUS, W., BOTO, P. & VANHAECHT, K. 2017. An International Study of Adherence to Guidelines for Patients Hospitalised with a COPD Exacerbation. COPD, 14, 156-163.
SHA, J., WORSNOP, C. J., LEAVER, B. A., VAGIAS, C., KINSELLA, P., RAHMAN, M. A. & MCDONALD, C. F. 2020. Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital. Intern Med J, 50, 453-459.
SHANMUGAM, G., BHUTANI, S., KHAN, D. A. & BROWN, E. S. 2007. Psychiatric considerations in pulmonary disease. Psychiatr Clin North Am, 30, 761-80.
SHARAFKHANEH, A., SOUTHARD, J. G., GOLDMAN, M., URYNIAK, T. & MARTIN, U. J. 2013. Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study. Respir Med, 106, 257-68.
SHAWON, M. S., PERRET, J. L., SENARATNA, C. V., LODGE, C., HAMILTON, G. S. & DHARMAGE, S. C. 2017. Current evidence on prevalence and clinical outcomes of co-morbid obstructive sleep apnea and chronic obstructive pulmonary disease: A systematic review. Sleep Med Rev, 32, 58-68.
SHEPPERD, S., HARWOOD, D., JENKINSON, C., GRAY, A., VESSEY, M. & MORGAN, P. 1998. Randomised controlled trial comparing hospital at home care with inpatient hospital care I: three month follow up of health outcomes. BMJ, 316, 1786-91.
SHIFFMAN, S. 2005. Nicotine lozenge efficacy in light smokers. Drug Alcohol Depend, 77, 311-4.
SHIFFMAN, S. & FERGUSON, S. G. 2008. Nicotine patch therapy prior to quitting smoking: a meta-analysis. Addiction, 103, 557-63.
SHIN, S. H., PARK, H. Y., KANG, D., CHO, J., KWON, S. O., PARK, J. H., LEE, J. S., OH, Y. M., SIN, D. D., KIM, W. J. & LEE, S. D. 2018. Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease. Respir Res, 19, 134.
SHIRTCLIFFE, P., MARSH, S., TRAVERS, J., WEATHERALL, M. & BEASLEY, R. 2012. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J, 42, 83-88.
SHIRTCLIFFE, P., WEATHERALL, M., MARSH, S., TRAVERS, J., HANSELL, A., MCNAUGHTON, A., ALDINGTON, S., MUELLEROVA, H. & BEASLEY, R. 2007. COPD prevalence in a random population survey: a matter of definition. European Respiratory Journal, 30, 232-239.
SHORR, A. F., DOYLE, J., STERN, L., DOLGITSER, M. & ZILBERBERG, M. D. 2008. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin, 24, 1123-30.
SHORR, A. F., SUN, X., JOHANNES, R. S., YAITANES, A. & TABAK, Y. P. 2011. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest, 140, 1177-83.
SHUAI, T., ZHANG, C., ZHANG, M., WANG, Y., XIONG, H., HUANG, Q. & LIU, J. 2021. Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis. PLoS One, 16, e0251348.
SIAFAKAS, N. M., VERMEIRE, P., PRIDE, N. B., PAOLETTI, P., GIBSON, J., HOWARD, P., YERNAULT, J. C., DECRAMER, M., HIGENBOTTAM, T., POSTMA, D. S. & ET AL. 1995. Optimal assessment and management of chronic obstructive pulmonary disease (COPD) The European Respiratory Society Task Force. Eur Respir J, 8, 1398-420.
SIDDIQUI, S. H., GUASCONI, A., VESTBO, J., JONES, P., AGUSTI, A., PAGGIARO, P., WEDZICHA, J. A. & SINGH, D. 2015. Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 192, 523-5.
SILVA, R. B., ALDORADIN-CABEZA, H., ESLICK, G. D., PHU, S. & DUQUE, G. 2017. The Effect of Physical Exercise on Frail Older Persons: A Systematic Review. J Frailty Aging, 6, 91-96.
SIMBERKOFF, M. S., CROSS, A. P., AL-IBRAHIM, M., BALTCH, A. L., GEISELER, P. J., NADLER, J., RICHMOND, A. S., SMITH, R. P., SCHIFFMAN, G., SHEPARD, D. S. & ET AL. 1986. Efficacy of pneumococcal vaccine in high-risk patients Results of a Veterans Administration Cooperative Study. N Engl J Med, 315, 1318-27.
SIMON, S. T., HIGGINSON, I. J., BOOTH, S., HARDING, R., WEINGARTNER, V. & BAUSEWEIN, C. 2016. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev, 10, Cd007354.
SIMONNEAU, G., ROBBINS, I. M., BEGHETTI, M., CHANNICK, R. N., DELCROIX, M., DENTON, C. P., ELLIOTT, C. G., GAINE, S. P., GLADWIN, M. T., JING, Z. C., KROWKA, M. J., LANGLEBEN, D., NAKANISHI, N. & SOUZA, R. 2009. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol, 54, S43-54.
SIN, D. D., BELL, N. R., SVENSON, L. W. & MAN, S. F. 2002. The impact of follow-up physician visits on emergency readmissions for patients with asthma and chronic obstructive pulmonary disease: a population-based study. Am J Med, 112, 120-5.
SINCLAIR, H. K., BOND, C. M. & STEAD, L. F. 2004. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev, 1, CD003698.
SINGH, B., MIELKE, M. M., PARSAIK, A. K., CHA, R. H., ROBERTS, R. O., SCANLON, P. D., GEDA, Y. E., CHRISTIANSON, T. J., PANKRATZ, V. S. & PETERSEN, R. C. 2014. a A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol, 71, 581-8.
SINGH, D., JONES, P. W., BATEMAN, E. D., KORN, S., SERRA, C., MOLINS, E., CARACTA, C., GIL, E. G. & LESELBAUM, A. 2014. b Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study. BMC Pulm Med, 14, 178.
SINGH, D., PAPI, A., CORRADI, M., PAVLISOVA, I., MONTAGNA, I., FRANCISCO, C., COHUET, G., VEZZOLI, S., SCURI, M. & VESTBO, J. 2016. a Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta₂-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. Lancet, 388, 963-73.
SINGH, G., ZHANG, W., KUO, Y. F. & SHARMA, G. 2016. b Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD. Chest, 149, 905-15.
SINGH, S. J., PUHAN, M. A., ANDRIANOPOULOS, V., HERNANDES, N. A., MITCHELL, K. E., HILL, C. J., LEE, A. L., CAMILLO, C. A., TROOSTERS, T., SPRUIT, M. A., CARLIN, B. W., WANGER, J., PEPIN, V., SAEY, D., PITTA, F., KAMINSKY, D. A., MCCORMACK, M. C., MACINTYRE, N., CULVER, B. H., SCIURBA, F. C., REVILL, S. M., DELAFOSSE, V. & HOLLAND, A. E. 2014. c An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J, 44, 1447-78.
SINGH, S., LOKE, Y. K. & FURBERG, C. D. 2008. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA, 300, 1439-50.
SIRAJ, R. A., MCKEEVER, T. M., GIBSON, J. E., GORDON, A. L. & BOLTON, C. E. 2020. Risk of incident dementia and cognitive impairment in patients with chronic obstructive pulmonary disease (COPD): A large UK population-based study. Respir Med, 177, 106288.
SIVAPALAN, P., INGEBRIGTSEN, T. S., RASMUSSEN, D. B., SORENSEN, R., RASMUSSEN, C. M., JENSEN, C. B., ALLIN, K. H., EKLOF, J., SEERSHOLM, N., VESTBO, J. & JENSEN, J. S. 2019. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months. BMJ Open Respir Res, 6, e000407.
SKAJAA, N., LAUGESEN, K., HORVÁTH-PUHÓ, E. & SØRENSEN, H. T. 2023. Comorbidities and mortality among patients with chronic obstructive pulmonary disease. BMJ Open Respir Res, 10, e001798.
SLATORE, C. G., BRYSON, C. L. & AU, D. H. 2009. The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med, 122, 472-8.
SMALLWOOD, N., ROSS, L., TAVERNER, J., JOHN, J., BAISCH, A., IRVING, L. & PHILIP, J. 2018. A Palliative Approach is Adopted for Many Patients Dying in Hospital with Chronic Obstructive Pulmonary Disease. COPD, 15, 503-511.
SMITH, C. B., KANNER, R. E., GOLDEN, C. A., KLAUBER, M. R. & RENZETTI, A. D., JR. 1980. Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis, 141, 271-80.
SMOLLER, J. W., POLLACK, M. H., OTTO, M. W., ROSENBAUM, J. F. & KRADIN, R. L. 1996. Panic anxiety, dyspnea, and respiratory disease Theoretical and clinical considerations. Am J Respir Crit Care Med, 154, Jun-17.
SOLER, N., TORRES, A., EWIG, S., GONZALEZ, J., CELIS, R., EL-EBIARY, M., HERNANDEZ, C. & RODRIGUEZ-ROISIN, R. 1998. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med, 157, 1498-505.
SOLTANI, A., REID, D., WILLS, K. & WALTERS, E. H. 2015. Prospective outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease presenting to hospital: a generalisable clinical audit. Intern Med J, 45, 925-33.
SORIANO, J. B., GARCIA-RIO, F., VAZQUEZ-ESPINOSA, E., CONFORTO, J. I., HERNANDO-SANZ, A., LOPEZ-YEPES, L., GALERA-MARTINEZ, R., PECES-BARBA, G., GOTERA-RIVERA, C. M., PEREZ-WARNISHER, M. T., SEGRELLES-CALVO, G., ZAMARRO, C., GONZALEZ-PONCE, P., RAMOS, M. I., JAFRI, S. & ANCOCHEA, J. 2018. A multicentre, randomized controlled trial of telehealth for the management of COPD. Respir Med, 144, 74-81.
SOURK, R. L. & NUGENT, K. M. 1983. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis, 128, 153-7.
SPECE, L. J., EPLER, E. M., DONOVAN, L. M., GRIFFITH, M. F., COLLINS, M. P., FEEMSTER, L. C. & AU, D. H. 2018. Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations. Ann Am Thorac Soc, 15, 1033-1038.
SPENCER, S., JONES, P. W. & GROUP, G. S. 2003. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax, 58, 589-93.
SPENCER, S., KARNER, C., CATES, C. J. & EVANS, D. J. 2011. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, CD007033.
SPIES, R., POTTER, M., HOLLAMBY, R., VAN DER WALT, S., HOHLFELD, A., OCHODO, E. & VAN ZYL-SMIT, R. 2023. Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Ann Am Thorac Soc, 20, 738-748.
SPITZER, R. L., WILLIAMS, J. B., KROENKE, K., LINZER, M., DEGRUY, F. V., 3RD, HAHN, S. R., BRODY, D. & JOHNSON, J. G. 1994. Utility of a new procedure for diagnosing mental disorders in primary care The PRIME-MD 1000 study. JAMA, 272, 1749-56.
SPRENKLE, M. D., NIEWOEHNER, D. E., MACDONALD, R., RUTKS, I. & WILT, T. J. 2004. Clinical Efficacy of OM-85 BV in COPD and Chronic Bronchitis: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease, 2, 167-175.
SPRUIT, M. A., GOSSELINK, R., TROOSTERS, T., KASRAN, A., GAYAN-RAMIREZ, G., BOGAERTS, P., BOUILLON, R. & DECRAMER, M. 2003. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax, 58, 752-6.
SPRUIT, M. A., SINGH, S. J., GARVEY, C., ZUWALLACK, R., NICI, L., ROCHESTER, C., HILL, K., HOLLAND, A. E., LAREAU, S. C., MAN, W. D., PITTA, F., SEWELL, L., RASKIN, J., BOURBEAU, J., CROUCH, R., FRANSSEN, F. M., CASABURI, R., VERCOULEN, J. H., VOGIATZIS, I., GOSSELINK, R., CLINI, E. M., EFFING, T. W., MALTAIS, F., VAN DER PALEN, J., TROOSTERS, T., JANSSEN, D. J., COLLINS, E., GARCIA-AYMERICH, J., BROOKS, D., FAHY, B. F., PUHAN, M. A., HOOGENDOORN, M., GARROD, R., SCHOLS, A. M., CARLIN, B., BENZO, R., MEEK, P., MORGAN, M., RUTTEN-VAN MOLKEN, M. P., RIES, A. L., MAKE, B., GOLDSTEIN, R. S., DOWSON, C. A., BROZEK, J. L., DONNER, C. F. & WOUTERS, E. F. 2013. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med, 188, e13-64.
SRIDHAR, M. K. & LEAN, M. E. J. 2006. Nutritional consequences of disease. Medicine, 34, 530-532.
SRIRAM, K. B. & PERCIVAL, M. 2016. Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients. Chron Respir Dis, 13, 13-22.
STANOJEVIC, S., KAMINSKY, D.A., MILLER, M.R., THOMPSON, B., ALIVERTI, A., BARJAKTAREVIC, I., COOPER, B.G., CULVER, B., DEROM, E., HALL, G.L. AND HALLSTRAND, T.S . 2022. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J, 60(1), 2101499.
STAPLETON, R. D., NIELSEN, E. L., ENGELBERG, R. A., PATRICK, D. L. & CURTIS, J. R. 2005. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest, 127, 328-34.
STEAD, L. F., BUITRAGO, D., PRECIADO, N., SANCHEZ, G., HARTMANN-BOYCE, J. & LANCASTER, T. 2013. a Physician advice for smoking cessation. Cochrane Database Syst Rev, 5, CD000165.
STEAD, L. F., PERERA, R., BULLEN, C., MANT, D., HARTMANN-BOYCE, J., CAHILL, K. & LANCASTER, T. 2012. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 11, CD000146.
STEER, J., GIBSON, J. & BOURKE, S. C. 2012. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax, 67, 970-6.
STEPHAN, F., BARRUCAND, B., PETIT, P., REZAIGUIA-DELCLAUX, S., MEDARD, A., DELANNOY, B., COSSERANT, B., FLICOTEAUX, G., IMBERT, A., PILORGE, C., BERARD, L. & BI, P. O. P. S. G. 2015. High-Flow Nasal Oxygen vs Noninvasive Positive Airway Pressure in Hypoxemic Patients After Cardiothoracic Surgery: A Randomized Clinical Trial. JAMA, 313, 2331-9.
STOCKLEY, R. A., O’BRIEN, C., PYE, A. & HILL, S. L. 2000. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest, 117, 1638-45.
STOLZ, D., KOSTIKAS, K., LOEFROTH, E., FOGEL, R., GUTZWILLER, F. S., CONTI, V., CAO, H. & CLEMENS, A. 2019. Differences in COPD Exacerbation Risk Between Women and Men: Analysis From the UK Clinical Practice Research Datalink Data. Chest, 156, 674-684.
STOLZ, D., RASCH, H., LINKA, A., DI VALENTINO, M., MEYER, A., BRUTSCHE, M. & TAMM, M. 2008. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J, 32, 619-28.
STONE, I. S., BARNES, N. C., JAMES, W. Y., MIDWINTER, D., BOUBERTAKH, R., FOLLOWS, R., JOHN, L. & PETERSEN, S. E. 2016. Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease A Randomized Controlled Trial. Am J Respir Crit Care Med, 193, 717-26.
STORGAARD, L. H., HOCKEY, H. U., LAURSEN, B. S. & WEINREICH, U. M. 2018. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis, 13, 1195-1205.
STRANG, S., OSMANOVIC, M., HALLBERG, C. & STRANG, P. 2018. Family Caregivers’ Heavy and Overloaded Burden in Advanced Chronic Obstructive Pulmonary Disease. J Palliat Med, 21, 1768-1772.
SUGAWARA, K., TAKAHASHI, H., KASAI, C., KIYOKAWA, N., WATANABE, T., FUJII, S., KASHIWAGURA, T., HONMA, M., SATAKE, M. & SHIOYA, T. 2010. Effects of nutritional supplementation combined with low-intensity exercise in malnourished patients with COPD. Respir Med, 104, 1883-9.
SUISSA, S. 2022. Inhaled Corticosteroids and Mortality in COPD: Biases in Randomized Trials. Chest, 162, e333-e334.
SUISSA, S., COULOMBE, J. & ERNST, P. 2015. Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia. Chest, 148, 1177-83.
SULAIMAN, I., CUSHEN, B., GREENE, G., SEHEULT, J., SEOW, D., RAWAT, F., MACHALE, E., MOKOKA, M., MORAN, C. N., SARTINI BHREATHNACH, A., MACHALE, P., TAPPUNI, S., DEERING, B., JACKSON, M., MCCARTHY, H., MELLON, L., DOYLE, F., BOLAND, F., REILLY, R. B. & COSTELLO, R. W. 2017. Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 195, 1333-1343.
SUZUKI, M., MURO, S., ANDO, Y., OMORI, T., SHIOTA, T., ENDO, K., SATO, S., AIHARA, K., MATSUMOTO, M., SUZUKI, S., ITOTANI, R., ISHITOKO, M., HARA, Y., TAKEMURA, M., UEDA, T., KAGIOKA, H., HIRABAYASHI, M., FUKUI, M. & MISHIMA, M. 2012. A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med, 172, 878-86.
SUZUKI, Y., SATO, K., SATO, S., INOUE, S. & SHIBATA, Y. 2024. Antibiotic treatment for patients with exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respir Investig, 62, 663-668.
SWANNEY, M. P., RUPPEL, G., ENRIGHT, P. L., PEDERSEN, O. F., CRAPO, R. O., MILLER, M. R., JENSEN, R. L., FALASCHETTI, E., SCHOUTEN, J. P., HANKINSON, J. L., STOCKS, J. & QUANJER, P. H. 2008. Using the lower limit of normal for the FEV₁/FVC ratio reduces the misclassification of airway obstruction. Thorax, 63, 1046-51.
TABAK, Y. P., SUN, X., JOHANNES, R. S., GUPTA, V. & SHORR, A. F. 2009. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med, 169, 1595-602.
TAGIYEVA, N., DEVEREUX, G., FIELDING, S., TURNER, S. & DOUGLAS, G. 2016. Outcomes of Childhood Asthma and Wheezy Bronchitis A 50-Year Cohort Study. Am J Respir Crit Care Med, 193, 23-30.
TAN, D. J., LODGE, C. J., WALTERS, E. H., LOWE, A. J., BUI, D. S., BOWATTE, G., PHAM, J., ERBAS, B., HUI, J., HAMILTON, G. S., THOMAS, P. S., HEW, M., WASHKO, G., WOOD-BAKER, R., ABRAMSON, M. J., PERRET, J. L. & DHARMAGE, S. C. 2023. Longitudinal Asthma Phenotypes from Childhood to Middle-Age: A Population-based Cohort Study. Am J Respir Crit Care Med, 208, 132-141.
TAN, W. C., BOURBEAU, J., AARON, S. D., HOGG, J. C., MALTAIS, F., HERNANDEZ, P., MARCINIUK, D. D., CHAPMAN, K. R., TO, T., FITZGERALD, J. M., WALKER, B. L., ROAD, J., ZHENG, L., ZHOU, G., YAU, T., BENEDETTI, A., O’DONNELL, D. & SIN, D. D. 2019. The effects of marijuana smoking on lung function in older people. Eur Respir J, 54, 1900826.
TAN, W. C., BOURBEAU, J., NADEAU, G., WANG, W., BARNES, N., LANDIS, S. H., KIRBY, M., HOGG, J. C. & SIN, D. D. 2021. High eosinophil counts predict decline in FEV(1): results from the CanCOLD study. Eur Respir J, 57, 2000838.
TAN, W. C., VOLLMER, W. M., LAMPRECHT, B., MANNINO, D. M., JITHOO, A., NIZANKOWSKA-MOGILNICKA, E., MEJZA, F., GISLASON, T., BURNEY, P. G. & BUIST, A. S. 2012. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax, 67, 718-26.
TANG, C. Y., TAYLOR, N. F. & BLACKSTOCK, F. C. 2010. Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a systematic review. Physiotherapy, 96, Jan-13.
TANG, C. Y., TAYLOR, N. F., MCDONALD, C. F. & BLACKSTOCK, F. C. 2014. Level of adherence to the GOLD strategy document for management of patients admitted to hospital with an acute exacerbation of COPD. Respirology, 19, 1191-7.
TARPY, S. P. & CELLI, B. R. 1995. Long-term oxygen therapy. N Engl J Med, 333, 710-4.
TASHKIN, D. P., ALTOSE, M. D., CONNETT, J. E., KANNER, R. E., LEE, W. W. & WISE, R. A. 1996. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease The Lung Health Study Research Group. Am J Respir Crit Care Med, 153, 1802-11.
TASHKIN, D. P., LI, N., HALPIN, D., KLEERUP, E., DECRAMER, M., CELLI, B. & ELASHOFF, R. 2013. Annual rates of change in pre- vs post-bronchodilator FEV₁ and FVC over 4 years in moderate to very severe COPD. Respir Med, 107, 1904-11.
TASHKIN, D. P., RENNARD, S., HAYS, J. T., MA, W., LAWRENCE, D. & LEE, T. C. 2011. a Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest, 139, 591-9.
TASHKIN, D. P., RENNARD, S., TAYLOR HAYS, J., LAWRENCE, D., MARTON, J. P. & LEE, T. C. 2011. b Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med, 105, 1682-90.
TAVERNER, J., ROSS, L., BARTLETT, C., LUTHE, M., ONG, J., IRVING, L. & SMALLWOOD, N. 2019. Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease. Intern Med J, 49, 66-73.
TAYLOR, D., JENKINS, A. R., PARROTT, K., BENHAM, A., TARGETT, S. & JONES, A. W. 2021. Efficacy of unsupervised exercise in adults with obstructive lung disease: a systematic review and meta-analysis. Thorax, 76, 591-600.
TAYLOR, S. J. C., SOHANPAL, R., STEED, L., MARSHALL, K., CHAN, C., YAZIJI, N., BARRADELL, A. C., FONT-GILABERT, P., HEALEY, A., HOOPER, R., KELLY, M. J., MAMMOLITI, K. M., PRIEBE, S., RAJASEKARAN, A., ROBERTS, M., ROWLAND, V., SINGH, S. J., SMUK, M., UNDERWOOD, M., WASEEM, S., WHITE, P., WILEMAN, V. & PINNOCK, H. 2023. Tailored psychological intervention for anxiety or depression in COPD (TANDEM): a randomised controlled trial. Eur Respir J, 62(5), 2300432.
TEMEL, J. S., GREER, J. A., MUZIKANSKY, A., GALLAGHER, E. R., ADMANE, S., JACKSON, V. A., DAHLIN, C. M., BLINDERMAN, C. D., JACOBSEN, J., PIRL, W. F., BILLINGS, J. A. & LYNCH, T. J. 2010. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med, 363, 733-42.
TEO, E., LOCKHART, K., PURCHURI, S. N., PUSHPARAJAH, J., CRIPPS, A. W. & VAN DRIEL, M. L. 2017. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6, Cd010010.
TERADA, K., MURO, S., OHARA, T., KUDO, M., OGAWA, E., HOSHINO, Y., HIRAI, T., NIIMI, A., CHIN, K. & MISHIMA, M. 2010. Abnormal swallowing reflex and COPD exacerbations. Chest, 137, 326-32.
TERADA, K., MURO, S., SATO, S., OHARA, T., HARUNA, A., MARUMO, S., KINOSE, D., OGAWA, E., HOSHINO, Y., NIIMI, A., TERADA, T. & MISHIMA, M. 2008. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax, 63, 951-5.
TEYLAN, M., KANTOROWSKI, A., HOMSY, D., KADRI, R., RICHARDSON, C. & MOY, M. 2019. Physical activity in COPD: Minimal clinically important difference for medical events. Chron Respir Dis, 16, 1.48E+15.
THAON, I., THIEBAUT, A., JOCHAULT, L., LEFEBVRE, A., LAPLANTE, J. J. & DALPHIN, J. C. 2011. Influence of hay and animal feed exposure on respiratory status: a longitudinal study. Eur Respir J, 37, 767-74.
THERAPEUTIC GUIDELINES LIMITED. 2019. Therapeutic guidelines: antibiotic Volume 16. Melbourne, Therapeutic Guidelines Limited, .
THOMPSON, A. B., MUELLER, M. B., HEIRES, A. J., BOHLING, T. L., DAUGHTON, D., YANCEY, S. W., SYKES, R. S. & RENNARD, S. I. 1992. Aerosolized beclomethasone in chronic bronchitis Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis, 146, 389-95.
THORP, A. A., OWEN, N., NEUHAUS, M. & DUNSTAN, D. W. 2011. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med, 41, 207-15.
TOBACCO USE AND DEPENDENCE GUIDELINE PANEL. 2008. Treating tobacco use and dependence: 2008 update US Public Health Service Clinical Practice Guideline executive summary. Respir Care, 53, 1217-22.
TOELLE, B. G., XUAN, W., BIRD, T. E., ABRAMSON, M. J., ATKINSON, D. N., BURTON, D. L., JAMES, A. L., JENKINS, C. R., JOHNS, D. P., MAGUIRE, G. P., MUSK, A. W., WALTERS, E. H., WOOD-BAKER, R., HUNTER, M. L., GRAHAM, B. J., SOUTHWELL, P. J., VOLLMER, W. M., BUIST, A. S. & MARKS, G. B. 2013. Respiratory symptoms and illness in older Australians: the Burden of Obstructive Lung Disease (BOLD) study. Med J Aust, 198, 144-8.
TOMMELEIN, E., MEHUYS, E., VAN HEES, T., ADRIAENS, E., VAN BORTEL, L., CHRISTIAENS, T., VAN TONGELEN, I., REMON, J. P., BOUSSERY, K. & BRUSSELLE, G. 2014. Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial. Br J Clin Pharmacol, 77, 756-66.
TORRES-ROBLES, A., BENRIMOJ, S. I., GASTELURRUTIA, M. A., MARTINEZ-MARTINEZ, F., PEIRO, T., PEREZ-ESCAMILLA, B., ROGERS, K., VALVERDE-MERINO, I., VARAS-DOVAL, R. & GARCIA-CARDENAS, V. 2022. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial. BMJ Qual Saf, 31, 105-115.
TORRES-SANCHEZ, I., VALENZA, M. C., CABRERA-MARTOS, I., LOPEZ-TORRES, I., BENITEZ-FELIPONI, A. & CONDE-VALERO, A. 2017. Effects of an Exercise Intervention in Frail Older Patients with Chronic Obstructive Pulmonary Disease Hospitalized due to an Exacerbation: A Randomized Controlled Trial. COPD, 14, 37-42.
TRIVEDI, R., RICHARD, N., MEHTA, R. & CHURCH, A. 2014. Umeclidinium in patients with COPD: a randomised, placebo-controlled study. Eur Respir J, 43, 72-81.
TSAI, L. L., ALISON, J. A., MCKENZIE, D. K. & MCKEOUGH, Z. J. 2016. Physical activity levels improve following discharge in people admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease. Chron Respir Dis, 13, 23-32.
TSAI, L. L., MCNAMARA, R. J., MODDEL, C., ALISON, J. A., MCKENZIE, D. K. & MCKEOUGH, Z. J. 2017. Home-based telerehabilitation via real-time videoconferencing improves endurance exercise capacity in patients with COPD: The randomized controlled TeleR Study. Respirology, 22, 699-707.
TURNER, S. E., EASTWOOD, P. R., CECINS, N. M., HILLMAN, D. R. & JENKINS, S. C. 2004. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest, 126, 766-73.
U. S. PREVENTIVE SERVICES TASK FORCE, SIU, A. L., BIBBINS-DOMINGO, K., GROSSMAN, D. C., DAVIDSON, K. W., EPLING, J. W., JR., GARCIA, F. A., GILLMAN, M., KEMPER, A. R., KRIST, A. H., KURTH, A. E., LANDEFELD, C. S., MANGIONE, C. M., HARPER, D. M., PHILLIPS, W. R., PHIPPS, M. G. & PIGNONE, M. P. 2016. Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. JAMA, 315, 1372-7.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES . 1990. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Atlanta, Georgia, .
UCHIDA, H., SUZUKI, T., MAMO, D. C., MULSANT, B. H., KIKUCHI, T., TAKEUCHI, H., TOMITA, M., WATANABE, K., YAGI, G. & KASHIMA, H. 2009. Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan. J Anxiety Disord, 23, 477-81.
UKAWA, S., TAMAKOSHI, A., YATSUYA, H., YAMAGISHI, K., ANDO, M. & ISO, H. 2015. Association Between Average Daily Television Viewing Time and Chronic Obstructive Pulmonary Disease-Related Mortality: Findings From the Japan Collaborative Cohort Study. J Epidemiol, 25, 431-6.
ULRIK, C. S. 2014. Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis, 9, 331-8.
UZZAMAN, M. N., AGARWAL, D., CHAN, S. C., PATRICK ENGKASAN, J., HABIB, G. M. M., HANAFI, N. S., JACKSON, T., JEBARAJ, P., KHOO, E. M., MIRZA, F. T., PINNOCK, H., SHUNMUGAM, R. H. & RABINOVICH, R. A. 2022. Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis. Eur Respir Rev, 31, 220076.
VAN AGTEREN, J. E., CARSON, K. V., TIONG, L. U. & SMITH, B. J. 2016. Lung volume reduction surgery for diffuse emphysema. Cochrane Database Syst Rev, 10, Cd001001.
VAN AGTEREN, J. E., HNIN, K., GROSSER, D., CARSON, K. V. & SMITH, B. J. 2017. Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 2, Cd012158.
VAN BOVEN, J. F. M., LAVORINI, F., AGH, T., SADATSAFAVI, M., PATINO, O. & MURESAN, B. 2024. Cost-effectiveness and impact on healthcare utilization of interventions to improve medication adherence and outcomes in asthma and COPD: A systematic literature review. J Allergy Clin Immunol Pract, 2024, e20240103.
VAN BOVEN, J. F., CHAVANNES, N. H., VAN DER MOLEN, T., RUTTEN-VAN MOLKEN, M. P., POSTMA, M. J. & VEGTER, S. 2014. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med, 108, 103-13.
VAN DER MOLEN, T., VAN BOVEN, J. F., MAGUIRE, T., GOYAL, P. & ALTMAN, P. 2017. Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist. Br J Clin Pharmacol, 83, 192-201.
VAN DER PALEN, J., GINKO, T., KROKER, A., VAN DER VALK, P., GOOSENS, M., PADULLES, L., SEOANE, B., REKEDA, L. & GARCIA GIL, E. 2013. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. Expert Opin Drug Deliv, 10, 1023-31.
VAN DIJK, W. D., GUPTA, N., TAN, W. C. & BOURBEAU, J. 2014. Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review. COPD, 11, 113-20.
VAN EERD, E. A., VAN DER MEER, R. M., VAN SCHAYCK, O. C. & KOTZ, D. 2016. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 8, Cd010744.
VAN GEFFEN, W. H., DOUMA, W. R., SLEBOS, D. J. & KERSTJENS, H. A. 2016. Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD. Cochrane Database Syst Rev, 8, Cd011826.
VAN GEFFEN, W. H., SLEBOS, D. J., HERTH, F. J., KEMP, S. V., WEDER, W. & SHAH, P. L. 2019. Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med, 7, 313-324.
VAN GEFFEN, W. H., TAN, D. J., WALTERS, J. A. & WALTERS, E. H. 2023. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, Cd011600.
VANFLETEREN, L. E., FRANSSEN, F. M., USZKO-LENCER, N. H., SPRUIT, M. A., CELIS, M., GORGELS, A. P. & WOUTERS, E. F. 2011. Frequency and relevance of ischemic electrocardiographic findings in patients with chronic obstructive pulmonary disease. Am J Cardiol, 108, 1669-74.
VANFLETEREN, L. E., SPRUIT, M. A., GROENEN, M., GAFFRON, S., VAN EMPEL, V. P., BRUIJNZEEL, P. L., RUTTEN, E. P., OP ‘T ROODT, J., WOUTERS, E. F. & FRANSSEN, F. M. 2013. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 187, 728-35.
VARRASO, R., CHIUVE, S. E., FUNG, T. T., BARR, R. G., HU, F. B., WILLETT, W. C. & CAMARGO, C. A. 2015. Alternate Healthy Eating Index 2010 and risk of chronic obstructive pulmonary disease among US women and men: prospective study. BMJ, 350, h286.
VARRASO, R., FUNG, T. T., BARR, R. G., HU, F. B., WILLETT, W. & CAMARGO, C. A. J. 2007. a Prospective study of dietary patterns and chronic obstructive pulmonary disease among US women. Am J Clin Nutr, 86, 488–495.
VARRASO, R., FUNG, T. T., HU, F. B., WILLETT, W. & CAMARGO, C. A. 2007. Prospective study of dietary patterns and chronic obstructive pulmonary disease among US men. Thorax, 62, 786-91.
VEDEL-KROGH, S., NORDESTGAARD, B. G., LANGE, P., VESTBO, J. & NIELSEN, S. F. 2018. Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD. Eur Respir J, 51, 1800120.
VERBERKT, C. A., VAN DEN BEUKEN-VAN EVERDINGEN, M. H. J., SCHOLS, J., HAMELEERS, N., WOUTERS, E. F. M. & JANSSEN, D. J. A. 2020. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial. JAMA Intern Med, 180, 1306-1314.
VESTBO, J., ANDERSON, J. A., BROOK, R. D., CALVERLEY, P. M., CELLI, B. R., CRIM, C., MARTINEZ, F., YATES, J., NEWBY, D. E. & INVESTIGATORS, S. 2016. a Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. Lancet, 387, 1817-26.
VESTBO, J., ANDERSON, J. A., CALVERLEY, P. M., CELLI, B., FERGUSON, G. T., JENKINS, C., KNOBIL, K., WILLITS, L. R., YATES, J. C. & JONES, P. W. 2009. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 64, 939-43.
VESTBO, J., LEATHER, D., DIAR BAKERLY, N., NEW, J., GIBSON, J. M., MCCORKINDALE, S., COLLIER, S., CRAWFORD, J., FRITH, L., HARVEY, C., SVEDSATER, H. & WOODCOCK, A. 2016. b Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice. N Engl J Med, 375, 1253-60.
VESTBO, J., PAPI, A., CORRADI, M., BLAZHKO, V., MONTAGNA, I., FRANCISCO, C., COHUET, G., VEZZOLI, S., SCURI, M. & SINGH, D. 2017. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial. Lancet, 389, 1919-1929.
VESTBO, J., PRESCOTT, E., ALMDAL, T., DAHL, M., NORDESTGAARD, B. G., ANDERSEN, T., SORENSEN, T. I. & LANGE, P. 2006. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med, 173, 79-83.
VESTBO, J., SORENSEN, T., LANGE, P., BRIX, A., TORRE, P. & VISKUM, K. 1999. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet, 353, 1819-23.
VIEIRA, P. J., CHIAPPA, A. M., CIPRIANO, G., JR., UMPIERRE, D., ARENA, R. & CHIAPPA, G. R. 2014. Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients. Respir Med, 108, 609-20.
VIVODTZEV, I., TAMISIER, R., BAGUET, J. P., BOREL, J. C., LEVY, P. & PEPIN, J. L. 2014. Arterial stiffness in COPD. Chest, 145, 861-75.
VOGELMEIER, C., HEDERER, B., GLAAB, T., SCHMIDT, H., RUTTEN-VAN MOLKEN, M. P., BEEH, K. M., RABE, K. F. & FABBRI, L. M. 2011. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med, 364, 1093-1103.
VOLLMER, W. M., GISLASON, T., BURNEY, P., ENRIGHT, P. L., GULSVIK, A., KOCABAS, A. & BUIST, A. S. 2009. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J, 34, 588-97.
VONBANK, K., ZIESCHE, R., HIGENBOTTAM, T. W., STIEBELLEHNER, L., PETKOV, V., SCHENK, P., GERMANN, P. & BLOCK, L. H. 2003. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax, 58, 289-93.
VORRINK, S. N., KORT, H. S., TROOSTERS, T. & LAMMERS, J. W. 2011. Level of daily physical activity in individuals with COPD compared with healthy controls. Respir Res, 12, 33.
VOZORIS, N. T., FISCHER, H. D., WANG, X., STEPHENSON, A. L., GERSHON, A. S., GRUNEIR, A., AUSTIN, P. C., ANDERSON, G. M., BELL, C. M., GILL, S. S. & ROCHON, P. A. 2014. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J, 44, 332-40.
VOZORIS, N. T., WANG, X., FISCHER, H. D., BELL, C. M., O’DONNELL, D. E., AUSTIN, P. C., STEPHENSON, A. L., GILL, S. S. & ROCHON, P. A. 2016. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J, 48, 683-93.
WAGNER, E. H., AUSTIN, B. T. & VON KORFF, M. 1996. Organizing care for patients with chronic illness. Milbank Q, 74, 511-44.
WAKABAYASHI, K., GONZALEZ, M. A., DELHAYE, C., BEN-DOR, I., MALUENDA, G., COLLINS, S. D., SYED, A. I., GAGLIA, M. A., JR., TORGUSON, R., XUE, Z., SUDDATH, W. O., SATLER, L. F., KENT, K. M., LINDSAY, J., PICHARD, A. D. & WAKSMAN, R. 2010. Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction. Am J Cardiol, 106, 305-9.
WALKE, L. M., BYERS, A. L., TINETTI, M. E., DUBIN, J. A., MCCORKLE, R. & FRIED, T. R. 2007. Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med, 167, 2503-8.
WALKER, P. P., POMPILIO, P. P., ZANABONI, P., BERGMO, T. S., PRIKK, K., MALINOVSCHI, A., MONTSERRAT, J. M., MIDDLEMASS, J., SONC, S., MUNARO, G., MARUSIC, D., SEPPER, R., ROSSO, R., SIRIWARDENA, A. N., JANSON, C., FARRE, R., CALVERLEY, P. M. A. & DELLACA, R. L. 2018. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED) A Randomized Clinical Trial. Am J Respir Crit Care Med, 198, 620-628.
WALSH, A., PERREM, L., KHASHAN, A. S., HENRY, M. T. & NI CHROININ, M. 2019. Statins versus placebo for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 7, Cd011959.
WALSH, E. E., FALSEY, A. R. & HENNESSEY, P. A. 1999. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med, 160, 791-5.
WALTERS, J. A., TAN, D. J., WHITE, C. J. & WOOD-BAKER, R. 2018. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, Cd006897.
WALTERS, J. A., TAN, D. J., WHITE, C. J., GIBSON, P. G., WOOD-BAKER, R. & WALTERS, E. H. 2014. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD001288.
WALTERS, J. A., TANG, J. N., POOLE, P. & WOOD-BAKER, R. 2017. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 1, Cd001390.
WANG, J. X., ZHANG, S. M., LI, X. H., ZHANG, Y., XU, Z. Y. & CAO, B. 2016. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. Int J Infect Dis, 48, 40-5.
WANG, L. H., ZHAO, Y., CHEN, L. Y., ZHANG, L. & ZHANG, Y. M. 2020. The effect of a nurse-led self-management program on outcomes of patients with chronic obstructive pulmonary disease. Clin Respir J, 14, 148-157.
WANG, K., ZHAO, S., YAU, S. Z., WEI, Y., LI, Y. C., ORR, R. W., LAM, I. H., WU, Y., WONG, E. L., HUNG, C. T. & YEOH, E. K. 2024. Outcomes and hospital service use among patients with COPD in a nurse- and allied health-led clinic. JAMA Health Forum, 5, e241575.
WASCHKI, B., ALTER, P., ZELLER, T., MAGNUSSEN, C., NEUMANN, J. T., TWERENBOLD, R., SINNING, C., HERR, C., KAHNERT, K., FAHNDRICH, S., BLANKENBERG, S., RABE, K. F., WELTE, T., JORRES, R. A., VOGELMEIER, C. F., BALS, R. & WATZ, H. 2020. High-sensitivity troponin I and all-cause mortality in patients with stable COPD: An analysis of the COSYCONET study. Eur Respir J, 55, 1901314.
WASCHKI, B., KIRSTEN, A. M., HOLZ, O., MUELLER, K. C., SCHAPER, M., SACK, A. L., MEYER, T., RABE, K. F., MAGNUSSEN, H. & WATZ, H. 2015. Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 192, 295-306.
WATZ, H., PITTA, F., ROCHESTER, C. L., GARCIA-AYMERICH, J., ZUWALLACK, R., TROOSTERS, T., VAES, A. W., PUHAN, M. A., JEHN, M., POLKEY, M. I., VOGIATZIS, I., CLINI, E. M., TOTH, M., GIMENO-SANTOS, E., WASCHKI, B., ESTEBAN, C., HAYOT, M., CASABURI, R., PORSZASZ, J., MCAULEY, E., SINGH, S. J., LANGER, D., WOUTERS, E. F., MAGNUSSEN, H. & SPRUIT, M. A. 2014. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J, 44, 1521-37.
WATZ, H., TETZLAFF, K., WOUTERS, E. F., KIRSTEN, A., MAGNUSSEN, H., RODRIGUEZ-ROISIN, R., VOGELMEIER, C., FABBRI, L. M., CHANEZ, P., DAHL, R., DISSE, B., FINNIGAN, H. & CALVERLEY, P. M. 2016. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med, 4, 390-398.
WEBBER, E. M., LIN, J. S. & THOMAS, R. G. 2022. Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA, 327, 1812-1816.
WEDZICHA, J. A., AGUSTI, A., DONALDSON, G., CHUECOS, F., LAMARCA, R. & GARCIA GIL, E. 2016. a Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies. COPD, 13, 669-676.
WEDZICHA, J. A., BANERJI, D., CHAPMAN, K. R., VESTBO, J., ROCHE, N., AYERS, R. T., THACH, C., FOGEL, R., PATALANO, F., VOGELMEIER, C. F. & INVESTIGATORS, F. 2016. b Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. N Engl J Med, 374, 2222-34.
WEDZICHA, J. A., CALVERLEY, P. M., SEEMUNGAL, T. A., HAGAN, G., ANSARI, Z. & STOCKLEY, R. A. 2008. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med, 177, 19-26.
WEDZICHA, J. A., DECRAMER, M., FICKER, J. H., NIEWOEHNER, D. E., SANDSTROM, T., TAYLOR, A. F., D’ANDREA, P., ARRASATE, C., CHEN, H. & BANERJI, D. 2013. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med, 1, 199-209.
WEILL, D., BENDEN, C., CORRIS, P. A., DARK, J. H., DAVIS, R. D., KESHAVJEE, S., LEDERER, D. J., MULLIGAN, M. J., PATTERSON, G. A., SINGER, L. G., SNELL, G. I., VERLEDEN, G. M., ZAMORA, M. R. & GLANVILLE, A. R. 2015. A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 34, Jan-15.
WEISS, J. R., SERDENES, R., MADTHA, U., ZHAO, H., KIM, V., LOPEZ-PASTRANA, J., EAKIN, M. N., O’TOOLE, J., COOPER, C. B., WOODRUFF, P., KANNER, R. E., KRISHNAN, J. A., IYER, A. S., COUPER, D. & MORRISON, M. F. 2023. Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort J . Acad Consult Liaison Psychiatry, 64, 45-57.
WEITZENBLUM, E., SAUTEGEAU, A., EHRHART, M., MAMMOSSER, M. & PELLETIER, A. 1985. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 131, 493-8.
WELLS, J. M., WASHKO, G. R., HAN, M. K., ABBAS, N., NATH, H., MAMARY, A. J., REGAN, E., BAILEY, W. C., MARTINEZ, F. J., WESTFALL, E., BEATY, T. H., CURRAN-EVERETT, D., CURTIS, J. L., HOKANSON, J. E., LYNCH, D. A., MAKE, B. J., CRAPO, J. D., SILVERMAN, E. K., BOWLER, R. P. & DRANSFIELD, M. T. 2012. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med, 367, 913-21.
WESTERIK, J. A., METTING, E. I., VAN BOVEN, J. F., TIERSMA, W., KOCKS, J. W. & SCHERMER, T. R. 2017. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res, 18, 31.
WHITTERS, D. & STOCKLEY, R. A. 2013. Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management. Drugs Aging, 30, 215-25.
WIJEKULASURIYA, S., SA, Z., BADGERY-PARKER, T., LONG, J. C., BRAITHWAITE, J., CHAPMAN, D. G., LEVESQUE, J. F., WATSON, D. E., WESTBROOK, J. I. & MITCHELL, R. 2024. Factors affecting 12-month unplanned readmissions for chronic obstructive pulmonary disease patients: the effect of mental disorders in an Australian cohort. J Public Health (Oxf), 46, e419–e429.
WILDMAN, M. J., SANDERSON, C. F., GROVES, J., REEVES, B. C., AYRES, J. G., HARRISON, D., YOUNG, D. & ROWAN, K. 2009. Survival and quality of life for patients with COPD or asthma admitted to intensive care in a UK multicentre cohort: the COPD and Asthma Outcome Study (CAOS). Thorax, 64, 128-32.
WILKINSON, T. M., DONALDSON, G. C., HURST, J. R., SEEMUNGAL, T. A. & WEDZICHA, J. A. 2004. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 169, 1298-303.
WILLIAMS, J. E., GREEN, R. H., WARRINGTON, V., STEINER, M. C., MORGAN, M. D. & SINGH, S. J. 2012. Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index. Respir Med, 106, 390-6.
WILLIAMS, J. M., ANTHENELLI, R. M., MORRIS, C. D., TREADOW, J., THOMPSON, J. R., YUNIS, C. & GEORGE, T. P. 2012. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry, 73, 654-60.
WILLIAMS, M. T., JOHNSTON, K. N. & PAQUET, C. 2020. Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review. Int J Chron Obstruct Pulmon Dis, 15, 903-919.
WILSON, R. 1998. The role of infection in COPD. Chest, 113, 242S-248S.
WISE, R. A., ANZUETO, A., COTTON, D., DAHL, R., DEVINS, T., DISSE, B., DUSSER, D., JOSEPH, E., KATTENBECK, S., KOENEN-BERGMANN, M., PLEDGER, G. & CALVERLEY, P. 2013. Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med, 369, 1491-501.
WISE, R. A., CHAPMAN, K. R., SCIRICA, B. M., BHATT, D. L., DAOUD, S. Z., ZETTERSTRAND, S., REISNER, C. & GIL, E. G. 2019. Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial. JAMA, 321, 1693-1701.
WONG, C. X., CARSON, K. V. & SMITH, B. J. 2012. Home care by outreach nursing for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 4, CD000994.
WOODRUFF, P. G., BARR, R. G., BLEECKER, E., CHRISTENSON, S. A., COUPER, D., CURTIS, J. L., GOUSKOVA, N. A., HANSEL, N. N., HOFFMAN, E. A., KANNER, R. E., KLEERUP, E., LAZARUS, S. C., MARTINEZ, F. J., PAINE, R., 3RD, RENNARD, S., TASHKIN, D. P., HAN, M. K. & GROUP, S. R. 2016. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med, 374, 1811-21.
WOOTTON, S. L., NG, L. W., MCKEOUGH, Z. J., JENKINS, S., HILL, K., EASTWOOD, P. R., HILLMAN, D. R., CECINS, N., SPENCER, L. M., JENKINS, C. & ALISON, J. A. 2014. Ground-based walking training improves quality of life and exercise capacity in COPD. Eur Respir J, 44, 885-94.
WORLD HEALTH ORGANIZATION. 1999. Tobacco Free Initiative: Policies for Public Health. Geneva, WHO, .
WORLD HEALTH ORGANIZATION. 2002. Definition of Palliative Care. Geneva, WHO [available from: wwwwhoint/cancer/palliative/definition/en/] Accessed March 2017, .
WU, T. C., HUANG, Y. C., HSU, S. Y., WANG, Y. C. & YEH, S. L. 2007. Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease. Int J Vitam Nutr Res, 77, 272-9.
WUYTACK, F., DEVANE, D., STOVOLD, E., MCDONNELL, M., CASEY, M., MCDONNELL, T. J., GILLESPIE, P., RAYMAKERS, A., LACASSE, Y. & MCCARTHY, B. 2018. Comparison of outpatient and home-based exercise training programmes for COPD: A systematic review and meta-analysis. Respirology, 23, 272-283.
XIA, J., GU, S., LEI, W., ZHANG, J., WEI, H., LIU, C., ZHANG, H., LU, R., ZHANG, L., JIANG, M., HU, C., CHENG, Z., WEI, C., CHEN, Y., LU, F., CHEN, M., BI, H., LIU, H., YAN, C., TENG, H., YANG, Y., LIANG, C., GE, Y., HOU, P., LIU, J., GAO, W., ZHANG, Y., FENG, Y., TAO, C., HUANG, X., PAN, P., LUO, H., YUN, C. & ZHAN, Q. 2022. High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial. Crit Care, 26, 109.
XIA, N., WANG, H. & NIE, X. 2015. Inhaled Long-Acting beta₂-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis. PLoS One, 10, e0137904.
XIN, C., XIA, Z., JIANG, C., LIN, M. & LI, G. 2016. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence, 10, 1197-203.
XU, W., COLLET, J. P., SHAPIRO, S., LIN, Y., YANG, T., PLATT, R. W., WANG, C. & BOURBEAU, J. 2008. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med, 178, 913-20.
YANG, H., HUANG, D., LUO, J., LIANG, Z. & LI, J. 2023. The use of high-flow nasal cannula in patients with chronic obstructive pulmonary disease under exacerbation and stable phases: A systematic review and meta-analysis. Heart Lung, 60, 116-126.
YANG, I. A., FERRY, O. R., CLARKE, M. S., SIM, E. H. & FONG, K. M. 2023. a Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD002991.
YANG, M., LI, Y., JIANG, Y., GUO, S., HE, J. Q. & SIN, D. D. 2023. b Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis. Eur Respir J, 61, 2200302.
YANG, Y., WEI, L., WANG, S., KE, L., ZHAO, H., MAO, J., LI, J. & MAO, Z. 2022. The effects of pursed lip breathing combined with diaphragmatic breathing on pulmonary function and exercise capacity in patients with COPD: a systematic review and meta-analysis. Physiother Theory Pract, 38, 847-857.
YAO, G. Y., MA, Y. L., ZHANG, M. Q. & GAO, Z. C. 2013. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis. Respiration, 86, 254-60.
YOHANNES, A. M. & ERSHLER, W. B. 2011. a Anemia in COPD: a systematic review of the prevalence, quality of life, and mortality. Respir Care, 56, 644-52.
YOHANNES, A. M., JUNKES-CUNHA, M., SMITH, J. & VESTBO, J. 2017. Management of Dyspnea and Anxiety in Chronic Obstructive Pulmonary Disease: A Critical Review. J Am Med Dir Assoc, 18, 1096e1-1096e17.
YOHANNES, A. M., RAUE, P. J., KANELLOPOULOS, D., MCGOVERN, A., SIREY, J. A., KIOSSES, D. N., BANERJEE, S., SEIRUP, J. K., NOVITCH, R. S. & ALEXOPOULOS, G. S. 2016. Predictors of All-Cause Mortality in Patients With Severe COPD and Major Depression Admitted to a Rehabilitation Hospital. Chest, 149, 467-73.
YOHANNES, A. M., WILLGOSS, T. G. & VESTBO, J. 2011. b Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes. Respir Care, 56, 477-87.
YOU, Y. & SHI, G. C. 2020. Blood Eosinophils and Clinical Outcome of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Respiration, 100, 228-237.
YOU, Y., NI, Y. & SHI, G. 2022. Inhaled Corticosteroids and Mycobacterial Infection in Patients with Chronic Airway Diseases: A Systematic Review and Meta-Analysis. Respiration, 101, 970-980.
YU, S., ZHANG, J., FANG, Q. & TONG, Z. 2021. Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Am J Med Sci , 100, 228-237.
YUN, J. H., LAMB, A., CHASE, R., SINGH, D., PARKER, M. M., SAFERALI, A., VESTBO, J., TAL-SINGER, R., CASTALDI, P. J., SILVERMAN, E. K. & HERSH, C. P. 2018. Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol, 141, 2037-2047e10.
ZANABONI, P., DINESEN, B., HOAAS, H., WOOTTON, R., BURGE, A. T., PHILP, R., OLIVEIRA, C. C., BONDARENKO, J., TRANBORG JENSEN, T., MILLER, B. R. & HOLLAND, A. E. 2023. Long-Term Telerehabilitation or Unsupervised Training at Home for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Am J Respir Crit Care Med, 207, 865-875.
ZEIGER, R. S., TRAN, T. N., BUTLER, R. K., SCHATZ, M., LI, Q., KHATRY, D. B., MARTIN, U., KAWATKAR, A. A. & CHEN, W. 2018. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. J Allergy Clin Immunol Pract, 6, 944-954e5.
ZHANG, L., WANG, Y., YE, Y., GAO, J., ZHU, F. & MIN, L. 2023. Comparison of High-Flow Nasal Cannula with Conventional Oxygen Therapy in Patients with Hypercapnic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. J Chron Obstruct Pulmon Dis, 18, 895-906.
ZHANG, S., KING, D., ROSEN, V. M. & ISMAILA, A. S. 2020. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. Int J Chron Obstruct Pulmon Dis, 15, 417-438.
ZHANG, X., YIN, C., TIAN, W., LU, D. & YANG, X. 2020. Effects of cognitive behavioral therapy on anxiety and depression in patients with chronic obstructive pulmonary disease: A meta-analysis and systematic review. Clin Respir J, 14, 891-900.
ZHENG, Y., ZHU, J., LIU, Y., LAI, W., LIN, C., QIU, K., WU, J. & YAO, W. 2018. Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis. BMJ, 363, k4388.
ZHENG, Z., WU, Z., LIU, N., CHEN, P., HOU, P., WANG, X., FU, Y., LIANG, W. & CHEN, R. 2016. Silent aspiration in patients with exacerbation of COPD. Eur Respir J, 48, 570-3.
ZHOU, Y., WANG, X., ZENG, X., QIU, R., XIE, J., LIU, S., ZHENG, J., ZHONG, N. & RAN, P. 2006. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. Respirology, 11, 603-10.
ZHOU, Y., ZHONG, N. S., LI, X., CHEN, S., ZHENG, J., ZHAO, D., YAO, W., ZHI, R., WEI, L., HE, B., ZHANG, X., YANG, C., LI, Y., LI, F., DU, J., GUI, J., HU, B., BAI, C., HUANG, P., CHEN, G., XU, Y., WANG, C., LIANG, B., LI, Y., HU, G., TAN, H., YE, X., MA, X., CHEN, Y., HU, X., TIAN, J., ZHU, X., SHI, Z., DU, X., LI, M., LIU, S., YU, R., ZHAO, J., MA, Q., XIE, C., LI, X., CHEN, T., LIN, Y., ZENG, L., YE, C., YE, W., LUO, X., ZENG, L., YU, S., GUAN, W. J. & RAN, P. 2017. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease. N Engl J Med, 377, 923-935.
ZIELINSKI, J., TOBIASZ, M., HAWRYLKIEWICZ, I., SLIWINSKI, P. & PALASIEWICZ, G. 1998. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest, 113, 65-70.
ZIGMOND, A. & SNAITH, R. 1983. The hospital anxiety and depression scale. Acta Psychiatr Scand, 67, 361-70.
ZWAR, N. A., MARKS, G. B., HERMIZ, O., MIDDLETON, S., COMINO, E. J., HASAN, I., VAGHOLKAR, S. & WILSON, S. F. 2011. Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice. Med J Aust, 195, 168-71.
ZWAR, N. A., MENDELSOHN, C. P. & RICHMOND, R. L. 2014. Supporting smoking cessation. BMJ, 348, f7535.
ZWERINK, M., KERSTJENS, H. A., VAN DER PALEN, J., VAN DER VALK, P., BRUSSE-KEIZER, M., ZIELHUIS, G. & EFFING, T. 2016. (Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT. Respirology, 21, 497-503.